Delayed gastric emptying: Whom to test, how to test, and what to do

Current Treatment Options in Gastroenterology

Volumn 9, Issue 4, 2006, Pages 295-304

  Friedenberg, Frank K ^b   Parkman, Henry P ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; ANTIEMETIC AGENT; BOTULINUM TOXIN A; CURARE; DIPHENHYDRAMINE; DOMPERIDONE; ERYTHROMYCIN; GLUCOSE; METOCLOPRAMIDE; MEVINOLIN; ONDANSETRON; PROCHLORPERAZINE MALEATE; PROKINETIC AGENT; TEGASEROD; TRICYCLIC ANTIDEPRESSANT AGENT;

ABDOMINAL CRAMP; ABDOMINAL PAIN; AGITATION; ALERTNESS; AMENORRHEA; AMYOTROPHIC LATERAL SCLEROSIS; ANTIEMETIC ACTIVITY; BREATH ANALYSIS; CALORIC INTAKE; CHOLESTATIC HEPATITIS; CHRONIC DISEASE; CLINICAL FEATURE; COST OF ILLNESS; DEPRESSION; DIARRHEA; DIET THERAPY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG ANTAGONISM; DRUG CONTRAINDICATION; DRUG COST; DRUG EXCRETION; DRUG MEGADOSE; DYSTONIA; ELECTROSTIMULATION THERAPY; FAT INTAKE; FOOD INTAKE; GALACTORRHEA; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; GYNECOMASTIA; HUMAN; HYPERPROLACTINEMIA; HYPOTENSION; IMPOTENCE; INSOMNIA; ISOTOPE LABELING; JEJUNOSTOMY; LIVER TOXICITY; MANOMETRY; METABOLIC REGULATION; MUSCLE ATROPHY; MYASTHENIA GRAVIS; NAUSEA; NERVOUSNESS; NEUROLEPTIC MALIGNANT SYNDROME; NEUROMUSCULAR JUNCTION DISORDER; OBSTRUCTIVE JAUNDICE; OCULOGYRIC CRISIS; PARKINSONISM; PERIPHERAL NEUROPATHY; PSEUDOMEMBRANOUS COLITIS; PYLORUS; REVIEW; RHABDOMYOLYSIS; SATIETY; SEDATION; SIDE EFFECT; STOMACH ANTRUM; STOMACH EMPTYING; STOMACH PARESIS; STOMACH SCINTISCANNING; TARDIVE DYSKINESIA; TORTICOLLIS; TRISMUS; VOMITING;

EID: 33746559240     PISSN: 10928472     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11938-006-0011-x     Document Type: Review

References (45)

1. Soykan I, Sivri B, Sarosiek I, et al.: Demography, clinical characteristics, psychological profiles, treatment and long-term follow-up of patients with gastroparesis. Dig Dis Sci 1998, 43:2398-2404.
2. Frank JW, Saslow SB, Camilleri M, et al.: Mechanism of accelerated gastric emptying of liquids and hyperglycemia in patients with type II diabetes mellitus. Gastroenterology 1995, 109:755-765.
3. Kong MF, Horowitz M, Jones KL, et al.: Natural history of diabetic gastroparesis. Diabetes Care 1998, 22:503-507.
4. He CL, Soffer EE, Ferris CD, et al.: Loss of interstitial cells of Cajal and inhibitory innervation in insulin-dependent diabetes. Gastroenterology 2001, 121:427-434.
5. Sarnelli G, Caenepeel P, Geypens B, et al.: Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am J Gastroenterol 2003, 98:783-788.
6. Jebbink RJA, Samsom M, Bruijs PPM, et al.: Hyperglycemia induces abnormalities of gastric myoelectrical activity in patients with type 1 diabetes mellitus. Gastroenterology 1994, 107:1390-1397.
7. Hasler WL, Soudah HC, Dulai G, Owyang C: Mediation of hyperglycemia-evoked gastric slow-wave dysrhythmias by endogenous prostaglandins. Gastroenterology 1995, 108:727-736.
8. Lemann M, Dederding JP, Flourie B, et al.: Abnormal perception of visceral pain in response to gastric distension in chronic idiopathic dyspepsia. Dig Dis Sci 1991, 36:1249-1254.
9. Toogerwerf WA, Pasricha PJ, Kalloo AN, Schuster MM: Pain: the overlooked symptom in gastroparesis. Am J Gastroenterol 1999, 94:1029-1033.
10. Kim DY, Myung SJ, Camilleri M: Novel testing of human gastric motor and sensory functions: Rationale, methods, and potential applications in clinical practice. Am J Gastroenterol 2000, 95:3365-3373.
11. Guo JP, Maurer AH, Fisher RS, Parkman HP: Extending gastric emptying scintigraphy from two to four hours detects more patients with gastroparesis Dig Dis Sci 2001, 46:24-29.
12. Datz FL, Christian PE, Moore J: Gender-related differences in gastric emptying. J Nucl Med 1987, 28:1204-1207.
13. Parkman HP, Schwartz SS: Esophagitis and other gastrointestinal disorders associated with diabetic gastroparesis. Arch Intern Med 1987, 147:1477-1480.
14. Parkman HP, Harris AD, Krevsky B, et al.: Gastroduodenal motility and dysmotility: Update on techniques available for evaluation. Am J Gastroenterol 1995, 90:869-892.
15. Thomforde GM, Camilleri M, Phillips SF, Forstrom LA: Evaluation of an inexpensive screening scintigraphy test of gastric emptying. J Nucl Med 1995, 36:93-96.
16. Choi MG, Camilleri M, Burton DD, et al.: Reproducibility and simplification of 13C-octanoic acid breath test for gastric emptying of solids. Am J Gastroenterol 1998, 93:92-98.
17. Bromer MQ, Kantor SB, Wagner DA, et al.: Simultaneous measurement of gastric emptying with a simple muffin meal using [13C] octanoate breath test and scintigraphy in normal subjects and patients with dyspeptic symptoms. Dig Dis Sci 2002, 47:1657-1663.
18. Ghoos YF, Maes BD, Geypens BJ, et al.: Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test. Gastroenterology 1993, 104:1640-1647.
19. Soffer E, Thongsawat S: Clinical value of duodeno-jejunal manometry. Its usefulness in diagnosis and management of patients with gastrointestinal symptoms. Dig Dis Sci 1996, 41:859-863.
20. Mearin F, Camilleri M, Malagelada JR: Pyloric dysfunction in diabetics with recurrent nausea and vomiting. Gastroenterology 1986, 90:1919-1925.
21. Camilleri M, Brown ML, Malagelada JR: Relationship between impaired gastric emptying and abnormal gastrointestinal motility. Gastroenterology 1986, 91:94-99.
22. Friedenberg FK, Parkman HP: Management of delayed gastric emptying. Clin Gastroenterol Hepatol 2005, 3:642-646.
23. Lehmann R, Honegger RA, Feinle C, et al.: Glucose control is not improved by accelerating gastric emptying in patients with type 1 diabetes mellitus and gastroparesis. A pilot study with cisapride as a model drug. Exp Clin Endocrinol Diabetes 2003, 111:255-261.
24. Petiakis IE, Vrachassotakis N, Sciacca V, et al.: Hyperglycemia attenuates erythromycin-induced acceleration of solid phase gastric emptying in idiopathic and diabetic gastroparesis. Scand J Gastroenterol 1999, 34:396-403.
25. Brownlee M, Kroopf SS: Metoclopramide for gastroparesis diabeticorum. N Engl J Med 1974, 291:1257-1258.
26. Perkel MS, Moore C, Hersh T, Davidson ED: Metoclopramide therapy in patients with delayed gastric emptying. Dig Dis Sci 1979, 24:662-666.
27. McCallum RW, Ricci DA, Rakatansky H, et al.: A multicenter placebo-controlled clinical trial of oral metoclopramide in diabetic gastroparesis. Diabetes Care 1983, 6:463-467.
28. Ganzini L, Casey DE, Hoffman WF, McCall AL: The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders. Arch Intern Med 1993, 153:1469-1475.
29. Miller LG, Jankovic J: Metoclopramide-induced movement disorders. Clinical findings with a review of the literature. Arch Intern Med 1989, 149:2486-2492.
30. Lata PF, Pigarelli DL: Chronic metoclopramide therapy for diabetic gastroparesis. Ann Pharmacother 2003, 37:122-126.
31. Peeters TL: Erythromycin and other macrolides as prokinetic agents. Gastroenterology 1993, 105:1886-1899.
32. Patterson D, Abell T, Rothstein R, et al.: A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis. Am J Gastroenterol 1999, 94:1230-1234.
33. Watts GF, Armitage M, Sinclair J, Hill JD: Treatment of diabetic gastroparesis with oral domperidone. Diabetic Med 1985, 2:491-492.
34. Jones MP: Access options for withdrawn motility-modifying agents. Am J Gastroenterol 2002, 97:2184-2188.
35. DiBaise JK, Quigley EMM: Efficacy of prolonged administration of intravenous erythromycin in an ambulatory setting as treatment of severe gastroparesis. J Clin Gastroenterol 1999, 28:131-134.
36. Maganti K, Onyemere K, Jones MP: Oral erythromycin and symptomatic relief of gastroparesis: A systematic review. Am J Gastroenterol 2003, 98:259-263.
37. Erbas T, Varoglu E, Erbas B, et al.: Comparison of metoclopramide and erythromycin in the treatment of diabetic gastroparesis. Diabetes Care 1993, 16:1511-1514.
38. Di Stefano M, Vos R, Janssens J, Tack JF: Effect of tegaserod, a 5-HT4 receptor partial agonist, on interdigestive and postprandial gastrointestinal motility in healthy volunteers [abstract]. Gastroenterology 2003, 124:A163.
39. Degen L, Matzinger D, Merz M, et al.: Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects. Aliment Pharmacol Ther 2001, 15:1745-1751.
40. Tougas G, Chen Y, Luo D, et al.: Tegaserod improves gastric emptying in patients with gastroparesis and dyspeptic symptoms [abstract]. Gastroenterology 2003, 124:A54-A68.
41. Bromer MQ, Friedenberg F, Miller LS, et al.: Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis. Gastrointest Endosc 2005, 61:833-839.
42. Miller LS, Szych GA, Kantor SB, et al.: Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle. Am J Gastroenterol 2002, 97:1653-1660.
43. FrTedenberg F, Gollamudi S, Parkman HP: Review: the use of botulinum toxin for the treatment of gastrointestinal motility disorders. Dig Dis Sci 2004, 2:165-175.
44. Hotokezaka M, Adams RB, Miller AD, et al.: Laparoscopic percutaneous jejunostomy for long term enteral access. Surg Endosc 1996, 10:1008-1011.
45. Abell T, McCallum R, Hocking M, et al.: Gastric electrical stimulation for medically refractory gastroparesis. Gastroenterology 2003, 125:421-428.